EIF2A and glioblastoma: At the moment, we do not know how and if the different H3 mutations (H3.1K27M, H3.3K27M, or H3.3G34R/V) or their associated mutations contribute to the sensitivity of PED-GBM to increased phosphorylation of eIF2α.